Cardiogenic Shock
Conditions
Keywords
Cardiogenic Shock, vaso-inotropic score
Brief summary
Cardiogenic shock is a frequent reason for hospitalization in critical care units, with high mortality (50%). Several French registries have been created to improve knowledge of the prognostic factors of cardiogenic shock. In recent years, temporary mechanical circulatory support has become more important in cardiogenic shock. The monitoring of catecholamines is also performed with a global score: the vaso-inotropic score. The purpose of our study is to consider using these new data and techniques to create a cohort of cardiogenic shock within our critical care unit. This observational study is based on clinical, biological, and hemodynamic data recorded during the ICU stay of patients for cardiogenic shock. The primary endpoint is the relationship between the hemodynamic evolution of cardiogenic shock and in-hospital mortality.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients hospitalized in ICU for cardiogenic shock * Patient with cardiogenic shock as defined by the FRENSCHOCK2 study criteria
Exclusion criteria
* Patient with cardiogenic shock in the context of septic shock and hemorrhagic shock
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Percentage of in-hospital mortality after cardiogenic shock | 5 years | — |
| Vaso-inotropic score after cardiogenic shock | 5 years | vasoactive-inotropic score (VIS) Maximal VIS (VISmax) is calculated using the highest doses of vasoactive and inotropic medications administered. VISmax categories: 0-5, \>5-15, \>15-30, \>30-45, and \>45 points. |
Countries
France